GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zydus Lifesciences Ltd (BOM:532321) » Definitions » 5-Year Yield-on-Cost %

Zydus Lifesciences (BOM:532321) 5-Year Yield-on-Cost % : 0.61 (As of May. 13, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Zydus Lifesciences 5-Year Yield-on-Cost %?

Zydus Lifesciences's yield on cost for the quarter that ended in Dec. 2023 was 0.61.


The historical rank and industry rank for Zydus Lifesciences's 5-Year Yield-on-Cost % or its related term are showing as below:

BOM:532321' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.38   Med: 0.81   Max: 2.54
Current: 0.61


During the past 13 years, Zydus Lifesciences's highest Yield on Cost was 2.54. The lowest was 0.38. And the median was 0.81.


BOM:532321's 5-Year Yield-on-Cost % is ranked worse than
83.86% of 502 companies
in the Drug Manufacturers industry
Industry Median: 2.135 vs BOM:532321: 0.61

Competitive Comparison of Zydus Lifesciences's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Zydus Lifesciences's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zydus Lifesciences's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zydus Lifesciences's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Zydus Lifesciences's 5-Year Yield-on-Cost % falls into.



Zydus Lifesciences 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Zydus Lifesciences is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Zydus Lifesciences  (BOM:532321) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Zydus Lifesciences 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Zydus Lifesciences's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zydus Lifesciences (BOM:532321) Business Description

Traded in Other Exchanges
Address
Scheme No. 63, Sarkhej-Gandhinagar Highway, Zydus Corporate Park, Survey No. 536, Near Vaishnodevi Circle, Khoraj (Gandhinagar), Ahmedabad, GJ, IND, 382481
Zydus Lifesciences Ltd is a specialty and generic drug manufacturing company. The product portfolio of the group includes Active Pharmaceutical Ingredients, human formulations, Health and wellness, and Animal health and veterinary products. Its product brands include Aten, Falcigo, Nucoxia, Levoday, Metscore and Arzep among others. It has two segments Pharmaceuticals and Consumer Products. It generates majority of its revenue from the Pharmaceutical segment.

Zydus Lifesciences (BOM:532321) Headlines

No Headlines